ArticleFrontiers in public health2025
Integrating social and behavior change communication into mass drug administration campaigns for neglected tropical diseases: insights and best practices from Jimma, Ethiopia.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neglected tropical diseases (NTDs) remain a significant public health concern despite control efforts. Current control strategies rely heavily on mass drug administration (MDA), often overlooking complementary interventions like social and behavior change communication (SBCC). Given the complexity of behavior and its role in intervention uptake, this study explored experiences, best practices, and lessons learned from integrating a tailored SBCC approach into MDA campaigns in Jimma, Ethiopia. Methods: A descriptive qualitative study was conducted following the implementation of SBCC integrated into two MDA campaign for target NTDs (OV and STH) between June and September 2022 in Jimma, Ethiopia. Purposive sampling was used to select participants from community members and stakeholders involved in the implementation of the project. A total of four focus group discussions, five expert group discussions and 10 key informant interviews were conducted. Guided by the RE-AIM framework, data were collected through four focus group discussions, five expert group discussions, and 10 key informant interviews. The data analyses were facilitated by Atlas.ti version 7.1.5. Results: The study found that the intervention successfully reached diverse community groups through home visits, religious leaders, schools, and IEC materials, raising awareness and demand for MDA services. SBCC was integrated at key touch points, such as community registration, where early hygiene and NTD prevention education ensured informed participation. Community mobilization efforts, including local leaders and megaphones, expanded message reach, while schools and drug distributors amplified outreach and reinforced adherence. The approach was highly accepted, with stakeholders supporting its long-term sustainability and scale-up. However, challenges such as limited time, human resource constraints, and operational workload affected full integration and various adaptive strategies, helped improve implementation. Conclusion: Integrating SBCC into MDA campaigns showed strong potential in enhancing community engagement and improving treatment coverage in a context with behavioral and social barriers. While not universally required, SBCC may serve as a strategic complement in settings facing such challenges. The findings provide practical insights for guiding the context-specific application of SBCC to strengthen the effectiveness and sustainability of NTD interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.